Eagle Pharmaceuticals News

Eagle Pharmaceuticals Shares Are Trading Lower After the Company Announced a Nasdaq Listing Receipt.

Eagle Pharmaceuticals Shares Are Trading Lower After the Company Announced a Nasdaq Listing Receipt.

BenzingaMay 23 00:35

Express News | Eagle Pharmaceuticals Announces Receipt of Delisting Notification From Nasdaq

BreakingsMay 22 21:00

Sector Update: Health Care Stocks Softer Late Afternoon

Health care stocks eased late Monday afternoon, with the NYSE Health Care Index decreasing 0.1% and the Health Care Select Sector SPDR Fund (XLV) down 0.2%. The iShares Biotechnology ETF (IBB) fell 1.

MT NewswiresApr 16 03:59

Eagle Pharmaceuticals Says Phase 3 Data Show Amisulpride's Sustained Antiemetic Effect; Shares Rise

Eagle Pharmaceuticals (EGRX) shares climbed 9% in recent trading after the company said Monday that it will present phase III trial data showing that intravenous amisulpride may sustain an antiemetic

MT NewswiresApr 16 01:49

Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National Conference

Eagle Pharmaceuticals To Present Additional Data From Phase 3 Trial Showing Sustained Response of Amisulpride For Rescue Treatment of Postoperative Nausea and Vomiting At Upcoming ASPAN 2024 National

BenzingaApr 15 19:25

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 14:37

HROW, HCAT and EGRX Are Among After Hour Movers

Seeking AlphaApr 13 05:05

Eagle Pharmaceuticals Risks Nasdaq Delisting Over Filing Delays

TipRanksApr 13 04:34

Eagle Pharmaceuticals Announces Receipt Of Notification Of Deficiency From Nasdaq Regarding Requirement To Timely File Annual Report On Form 10-K

Eagle Pharmaceuticals Announces Receipt Of Notification Of Deficiency From Nasdaq Regarding Requirement To Timely File Annual Report On Form 10-K

BenzingaApr 13 04:09

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency From Nasdaq Regarding Requirement to Timely File Annual Report On Form 10-K

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency From Nasdaq Regarding Requirement to Timely File Annual Report On Form 10-K.

GlobeNewswireApr 13 04:05

Sector Update: Health Care

Health care stocks fell late Monday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both easing 0.1%, paring earlier losses. The iShares Biotechnology ETF (

MT NewswiresMar 12 03:28

Eagle Pharmaceuticals CFO Resigns; Shares Fall

Eagle Pharmaceuticals (EGRX) shares fell 6% in recent Monday trading after Brian Cahill resigned as chief financial officer on Friday, effective immediately. The company said in a regulatory filing th

MT NewswiresMar 12 02:05

Eagle Pharmaceuticals Announces CFO Transition and Leadership Changes

TipRanksMar 9 06:03

Eagle Pharmaceuticals Announces Workforce Reduction

InvestingMar 1 00:02

Eagle Pharmaceuticals Faces Nasdaq Delisting Deadline

TipRanksFeb 13 22:02

Eagle Pharmaceuticals Updates Bendamustine IP Portfolio

TipRanksJan 19 16:04

Eagle Pharmaceuticals Provides Update on Bendamustine Intellectual Property Portfolio

WOODCLIFF LAKE, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) ("Eagle" or the "Company") today provided an update on its bendamustine intellectual property portfolio. On January

GlobeNewswireJan 18 19:50

Lifshitz Law PLLC Announces Investigations of Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX), ON...

Stockhouse Dec 16, 2023 08:37

Eagle Pharmaceuticals to Present Abstract on Post-hoc Analysis of Amisulpride at the 77th PGA (PostGraduate Assembly in Anesthesiology) in New York City

-- BARHEMSYS (amisulpride) Injection is the first and only antiemetic approved by the U.S. Food and Drug Administration ("FDA") for rescue treatment of postoperative nausea and vomiting ("PONV") despite

GlobeNewswireDec 7, 2023 05:05

Eagle Pharmaceuticals, Inc. (EGRX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages...

Stockhouse Dec 4, 2023 01:20